Detalhe da pesquisa
1.
Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in Indonesia.
J Antimicrob Chemother
; 79(5): 977-986, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459759
2.
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Eur Respir J
; 61(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328357
3.
Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia.
Emerg Infect Dis
; 28(3): 660-671, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202524
4.
Towards elimination of childhood and adolescent tuberculosis in the Netherlands: an epidemiological time-series analysis of national surveillance data.
Eur Respir J
; 56(4)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32471938
5.
Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands.
Eur Respir J
; 54(6)2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515410
6.
Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
Respir Res
; 19(1): 256, 2018 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563522
7.
Optimizing Antimicrobial and Host-Directed Therapies to Improve Clinical Outcomes of Childhood Tuberculous Meningitis.
Clin Infect Dis
; 75(2): 360-361, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910810
8.
Pharmacokinetics of standard versus high-dose rifampin for tuberculosis preventive treatment: a sub-study of the 2R2 randomized controlled trial.
Int J Antimicrob Agents
; : 107197, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750674
9.
Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis.
Arch Dis Child
; 107(1): 70-77, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34183327
10.
Antituberculosis Drug-induced Liver Injury in Children: Incidence and Risk Factors During the Two-month Intensive Phase of Therapy.
Pediatr Infect Dis J
; 38(1): 50-53, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30234790